These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21194556)

  • 1. Leptin controls ketone body utilization in hypothalamic neuron.
    Narishima R; Yamasaki M; Hasegawa S; Yoshida S; Tanaka S; Fukui T
    Neurosci Lett; 2011 Mar; 490(3):185-90. PubMed ID: 21194556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic obesity affects neural ketone body utilization in the rat brain.
    Narishima R; Yamasaki M; Hasegawa S; Fukui T
    Obesity (Silver Spring); 2009 Mar; 17(3):611-5. PubMed ID: 19219059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different localization in rat brain of the novel cytosolic ketone body-utilizing enzyme, acetoacetyl-CoA synthetase, as compared to succinyl-CoA:3-oxoacid CoA-transferase.
    Ohnuki M; Takahashi N; Yamasaki M; Fukui T
    Biochim Biophys Acta; 2005 Jul; 1729(3):147-53. PubMed ID: 15992942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat diet-induced obesity stimulates ketone body utilization in osteoclasts of the mouse bone.
    Yamasaki M; Hasegawa S; Imai M; Takahashi N; Fukui T
    Biochem Biophys Res Commun; 2016 Apr; 473(2):654-61. PubMed ID: 27021680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketone body utilization is regulated by male-specific factors in rat subcutaneous adipocytes.
    Yamasaki M; Hasegawa S; Yamanaka H; Narishima R; Fukui T
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):170-4. PubMed ID: 19085696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity.
    Mountjoy PD; Bailey SJ; Rutter GA
    Diabetologia; 2007 Jan; 50(1):168-77. PubMed ID: 17093945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, by legumain in the mouse kidney.
    Hasegawa S; Yamasaki M; Fukui T
    Biochem Biophys Res Commun; 2014 Oct; 453(3):631-5. PubMed ID: 25301556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels.
    Hasegawa S; Noda K; Maeda A; Matsuoka M; Yamasaki M; Fukui T
    Mol Genet Metab; 2012 Nov; 107(3):553-60. PubMed ID: 22985732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of acetoacetyl-CoA synthetase, a novel cytosolic ketone body-utilizing enzyme, in human brain.
    Ohgami M; Takahashi N; Yamasaki M; Fukui T
    Biochem Pharmacol; 2003 Mar; 65(6):989-94. PubMed ID: 12623130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose, insulin, and leptin signaling pathways modulate nitric oxide synthesis in glucose-inhibited neurons in the ventromedial hypothalamus.
    Canabal DD; Song Z; Potian JG; Beuve A; McArdle JJ; Routh VH
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1418-28. PubMed ID: 17170237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetoacetyl-CoA synthetase is essential for normal neuronal development.
    Hasegawa S; Kume H; Iinuma S; Yamasaki M; Takahashi N; Fukui T
    Biochem Biophys Res Commun; 2012 Oct; 427(2):398-403. PubMed ID: 23000407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetoacetyl-CoA synthetase gene is abundant in rat adipose, and related with fatty acid synthesis in mature adipocytes.
    Yamasaki M; Hasegawa S; Suzuki H; Hidai K; Saitoh Y; Fukui T
    Biochem Biophys Res Commun; 2005 Sep; 335(1):215-9. PubMed ID: 16055091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans.
    Steinberg GR; McAinch AJ; Chen MB; O'Brien PE; Dixon JB; Cameron-Smith D; Kemp BE
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3592-7. PubMed ID: 16822822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific cleavage of acetoacetyl-CoA synthetase by legumain.
    Hasegawa S; Inoue D; Yamasaki M; Li C; Imai M; Takahashi N; Fukui T
    FEBS Lett; 2016 Jun; 590(11):1592-601. PubMed ID: 27129883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats.
    Shimizu H; Arima H; Watanabe M; Goto M; Banno R; Sato I; Ozaki N; Nagasaki H; Oiso Y
    Endocrinology; 2008 Sep; 149(9):4544-53. PubMed ID: 18535107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated STAT3 messenger ribonucleic acid and STAT3 protein in the hypothalamic arcuate nucleus of the obese leptin-deficient (ob/ob) mouse.
    Håkansson-Ovesjö ML; Collin M; Meister B
    Endocrinology; 2000 Nov; 141(11):3946-55. PubMed ID: 11089524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of acetoacetyl-CoA synthetase by Sp1 in neuroblastoma cells.
    Hasegawa S; Imai M; Yamasaki M; Takahashi N; Fukui T
    Biochem Biophys Res Commun; 2018 Jan; 495(1):652-658. PubMed ID: 29137983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
    Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
    Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the Transcriptional Targets of Leptin Reveals a Role for
    Allison MB; Pan W; MacKenzie A; Patterson C; Shah K; Barnes T; Cheng W; Rupp A; Olson DP; Myers MG
    Diabetes; 2018 Jun; 67(6):1093-1104. PubMed ID: 29535089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in hypothalamic expression levels of galanin-like peptide in rat and mouse models support that it is a leptin-target peptide.
    Kumano S; Matsumoto H; Takatsu Y; Noguchi J; Kitada C; Ohtaki T
    Endocrinology; 2003 Jun; 144(6):2634-43. PubMed ID: 12746327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.